The National Health Surveillance Agency (ANVISA) has approved corrections and improvements to Resolution of the Collegiate Board (RDC) 989/2025, which regulates procedures for sanitary products. The amendments aim to modernize and streamline regulatory processes, making them more efficient and accessible to the industry.
RDC 989/2025 establishes specific technical and administrative guidelines for the evaluation, registration, and commercialization of sanitary products in Brazil. With the approved corrections, ANVISA reinforces its commitment to maintaining rigorous standards of safety and efficacy, while reducing bureaucratic complexity for manufacturers and distributors.
These improvements reflect ANVISA's ongoing review of regulatory standards, considering experience accumulated since the initial publication of the resolution. The enhancements cover procedural aspects that facilitate understanding and implementation of regulatory requirements by sector companies.
The sanitary products sector is strategic for public health, responsible for ensuring the effectiveness of environmental hygiene and disinfection. The update of standards demonstrates ANVISA's commitment to following technological evolution and international best practices.
Companies interested should consult the full text of RDC 989/2025 with the approved corrections on the ANVISA portal. The measure reinforces dialogue between the regulatory agency and industry, contributing to a more predictable and sustainable regulatory environment.
